封面
市場調查報告書
商品編碼
1609984

螢光血管造影術市場規模、佔有率、趨勢分析報告:按類型、應用、最終用途、地區、細分市場預測,2025-2030 年

Fluorescein Angiography Market Size, Share & Trends Analysis Report By Type (Traditional Fluorescein Angiography), By Application (Age-related Macular Degeneration), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

螢光血管造影術市場成長與趨勢

Grand View Research, Inc.的最新報告顯示,到2030年終,全球螢光素血管造影術市場規模預計將達到13.9億美元,2025年至2030年複合年成長率為8.5%。黃斑部病變和糖尿病視網膜病變等眼部疾病的盛行率不斷上升以及技術的快速進步是一些影響市場的促進因素。然而,人們對 OCT 和眼底螢光等更安全、更快速的替代品的日益偏好預計將阻礙預測期內的市場成長。

該國的醫院和診斷成像中心等終端用戶已有效採用基於人工智慧的眼底攝影機來檢測各種致盲疾病。例如,2019年1月,廣東省德清縣醫院使用中山大學與百度(一家提供搜尋引擎平台等服務的中國跨國科技公司)共同開發的AI鏡頭,為我們進行免費體檢,以發現疾病。這款AI眼底攝影機可以診斷青光眼、糖尿病視網膜病變、黃斑部病變。

螢光素血管造影術經常被用作多種眼科疾病的確診測試,儘管其替代方案是首選。該技術提供準確、高品質的影像,有助於高效的治療方法選擇。此外,開發中國家對傳統螢光血管造影術的需求仍然很高。這是由於負擔能力和產品可用性。

螢光血管血管造影術市場報告亮點

  • 傳統螢光血管造影術佔據市場主導地位,2024 年佔最大收益佔有率為 56.4%。
  • 老齡化黃斑部病變(AMD)應用將在2024年佔據最大的收益佔有率,達到32.6%,由於這種疾病在老齡化人群中的患病率不斷增加,佔據市場主導地位。
  • 醫院和診所領域引領市場,2024 年佔最大收益佔有率,達 63.9%。
  • 北美螢光素血管造影術市場主導全球市場,2024年佔最大收益佔有率為36.4%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章螢光血管造影術市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章螢光血管造影術市場:類型業務分析

  • 類型市場佔有率,2024 年和 2030 年
  • 類型細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析(按類型)
  • 傳統螢光造影(FA)
  • 共焦掃描雷射檢眼鏡 (cSLO) FA

第5章螢光血管造影術市場:應用商業分析

  • 2024年及2030年應用市場佔有率
  • 使用細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析(按應用)
  • 老齡化黃斑部病變(AMD)
  • 糖尿病視網膜病變
  • 視網膜靜脈阻塞
  • 葡萄膜炎和視網膜血管炎
  • 脈絡膜腫瘤
  • 其他

第6章螢光血管造影術市場:最終用途商業分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 醫院/診所
  • 門診手術中心
  • 其他

第 7 章螢光血管造影術市場:區域、估計與趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Carl Zeiss Meditec, Inc.
    • NIDEK Co., Ltd.
    • Kowa Company Ltd.
    • Topcon Medical Systems, Inc.
    • Optomed Oy Ltd.
    • CenterVue SpA
    • Canon, Inc.
Product Code: GVR-4-68038-554-0

Fluorescein Angiography Market Growth & Trends:

The global fluorescein angiography market size is expected to reach USD 1.39 billion by the end of 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Fluorescein Angiography Market Report Highlights:

  • Traditional fluorescein angiography dominated the market and accounted for the largest revenue share of 56.4% in 2024, attributed to the rising incidence of eye diseases, particularly diabetic retinopathy and age-related macular degeneration.
  • The age-related macular degeneration (AMD) application held the dominant position in the market, with the largest revenue share of 32.6% in 2024, owing to the increasing prevalence of this condition among the aging population.
  • The hospitals and clinics segment led the market and accounted for the largest revenue share of 63.9% in 2024 attributed to the increasing prevalence of eye diseases, particularly among the aging population.
  • The fluorescein angiography market in North America dominated the global market and accounted for the largest revenue share of 36.4% in 2024 attributed to the high prevalence of eye diseases, particularly diabetic retinopathy, which affects millions of individuals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fluorescein Angiography Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fluorescein Angiography Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Traditional Fluorescein Angiography (FA)
    • 4.4.1. Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
  • 4.5. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA
    • 4.5.1. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)

Chapter 5. Fluorescein Angiography Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Age-related Macular Degeneration (AMD)
    • 5.4.1. Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
  • 5.5. Diabetic Retinopathy
    • 5.5.1. Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
  • 5.6. Retinal Vein Occlusion
    • 5.6.1. Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
  • 5.7. Uveitis and Retinal Vasculitis
    • 5.7.1. Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
  • 5.8. Choroidal Tumors
    • 5.8.1. Choroidal Tumors Market, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Fluorescein Angiography Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals and Clinics
    • 6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Fluorescein Angiography Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Carl Zeiss Meditec, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Type Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. NIDEK Co., Ltd.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Type Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Kowa Company Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Type Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Topcon Medical Systems, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Type Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Optomed Oy (Ltd.)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Type Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. CenterVue SpA
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Type Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Canon, Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Type Benchmarking
      • 8.5.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Fluorescein Angiography Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 UK Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 UK Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 France Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Spain Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Norway Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Norway Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Denmark Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Denmark Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Sweden Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 China Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 China Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 India Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 South Korea Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fluorescein Angiography Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Type, Application Outlook (USD Million)
  • Fig. 10 End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Fluorescein Angiography Market Dynamics
  • Fig. 13 Fluorescein Angiography Market: Porter's Five Forces Analysis
  • Fig. 14 Fluorescein Angiography Market: PESTLE analysis
  • Fig. 15 Fluorescein Angiography Market: Type Segment Dashboard
  • Fig. 16 Fluorescein Angiography Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 17 Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
  • Fig. 18 Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)
  • Fig. 19 Fluorescein Angiography Market: Application Segment Dashboard
  • Fig. 20 Fluorescein Angiography Market: Application Market Share Analysis, 2024 & 2030
  • Fig. 21 Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
  • Fig. 22 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
  • Fig. 24 Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
  • Fig. 25 Choroidal Tumors Market, 2018 - 2030 (USD Million)
  • Fig. 26 Others Market, 2018 - 2030 (USD Million)
  • Fig. 27 Fluorescein Angiography Market: End Use Segment Dashboard
  • Fig. 28 Fluorescein Angiography Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 29 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 30 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market, 2018 - 2030 (USD Million)
  • Fig. 32 Fluorescein Angiography Market Revenue, By Region
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 North America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Country Dynamics
  • Fig. 37 U.S. Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Country Dynamics
  • Fig. 39 Canada Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Country Dynamics
  • Fig. 41 Mexico Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Country Dynamics
  • Fig. 44 UK Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Country Dynamics
  • Fig. 46 Germany Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 47 France Country Dynamics
  • Fig. 48 France Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy Country Dynamics
  • Fig. 50 Italy Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Country Dynamics
  • Fig. 52 Spain Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway Country Dynamics
  • Fig. 54 Norway Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Country Dynamics
  • Fig. 56 Sweden Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark Country Dynamics
  • Fig. 58 Denmark Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Country Dynamics
  • Fig. 61 Japan Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 62 China Country Dynamics
  • Fig. 63 China Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 64 India Country Dynamics
  • Fig. 65 India Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia Country Dynamics
  • Fig. 67 Australia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea Country Dynamics
  • Fig. 69 South Korea Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand Country Dynamics
  • Fig. 71 Thailand Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil Country Dynamics
  • Fig. 74 Brazil Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina Country Dynamics
  • Fig. 76 Argentina Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa Country Dynamics
  • Fig. 79 South Africa Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia Country Dynamics
  • Fig. 81 Saudi Arabia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 82 UAE Country Dynamics
  • Fig. 83 UAE Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait Key Country Dynamicss
  • Fig. 85 Kuwait Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 86 Company Categorization
  • Fig. 87 Company Market Position Analysis
  • Fig. 88 Strategic Framework